Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
about
Comparison of echinocandin antifungalsEpidemiology of invasive candidiasis: a persistent public health problemAnidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.Candida infections and their prevention.FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropeniaReverse line blot hybridization assay for identification of medically important fungi from culture and clinical specimens.In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.Echinocandin antifungals: review and update.Developments in the treatment of candidiasis: more choices and new challenges.Anidulafungin: a new echinocandin for candidal infections.Anidulafungin--state of affairs from a clinical perspective.Treatment options in candidaemia.Resistance to echinocandin-class antifungal drugs.Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibilityCurrent perspectives on echinocandin class drugs.Pediatric antifungal agents.Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?The use of antifungal therapy in neonatal intensive care.Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials.Anidulafungin in treatment of experimental invasive infection by Candida parapsilosis: in vitro activity, (1-->3)-beta-D-glucan and mannan serum levels, histopathological findings, and in vivo efficacy.Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin.FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.Early clinical experience with anidulafungin at a large tertiary care medical center.Tissue distribution of anidulafungin in neonatal rats.
P2860
Q28273738-02289410-5896-4855-9430-6E67D6BCDDD1Q29616758-F5AB5716-0FDA-4D4E-8078-AFBD650682F3Q33490772-7A26816D-138F-463A-95B9-4CCFAAADF899Q33775256-31BD6925-8B6C-45E7-B175-792A966E02A0Q34737334-6FC79C07-A5D6-4CB6-A404-F480041EBECDQ35647785-A4CFBCA0-C501-4FA0-BAA8-A18CDD56C0DBQ36098693-526A2819-7E29-416F-86E0-1EB601496003Q36425025-48A79532-49C2-48CC-A50E-735D0ECE9AD6Q36441524-C6E5136C-E0D7-4827-AFC5-854391820273Q36623050-C44D7CB8-A985-4B7F-BDF9-7340AA89C79DQ36723788-4B7D10AC-44C8-4BC4-9476-056E5F345759Q36774257-7E32467B-4040-4DAD-A219-5E8830CA1CBDQ36774262-3311D9F8-DF3F-4A74-9E49-46C4424D47ABQ36849595-F6967D5E-A1F2-44D8-A06A-69EE14DA89D7Q37544444-BB5F11CD-002F-4FF2-A029-26DF0347A23FQ37554055-4135F888-28F3-452D-A2C1-AF2033098DACQ37594515-615AE014-B315-447E-BD51-AE177FBC62F5Q37785979-B9975145-3FA8-4911-8DDA-D2082B97B356Q37854724-166960A9-D12B-4698-B153-325EA48E2C5BQ37985070-BA23C85B-3A7E-4036-A845-6764190E5DE4Q38027469-C5FB2F18-9CAD-499D-928E-DECE2ACDFCD5Q38056762-8CFD59AE-588F-406C-AE9C-48152E8720EAQ38726218-DC49A5B1-A34E-4941-B021-B0DD461A2D49Q38811035-7EAB2A97-FF8B-4D04-9FC4-58CCDA543828Q41787736-C5E48BCA-3491-4465-AC0A-79C2A72424E5Q42035300-3014E6FB-0E48-4880-AF1A-B29473C45C4AQ42250085-74B63974-C968-4818-962F-E3C628E6B242Q46836740-FAFFF424-7E74-4C05-B014-26BE0416A80BQ48670237-45DD933D-FB8C-4A3C-BE04-F7FEE4F0D32B
P2860
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis
@nl
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
@ast
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
@en
type
label
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis
@nl
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
@ast
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
@en
prefLabel
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis
@nl
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
@ast
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.
@en
P2093
P2860
P921
P1476
Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis
@en
P2093
B P Goldstein
M A Pfaller
R J Hollis
S A Messer
S Tendolkar
P2860
P304
P356
10.1128/AAC.49.11.4795-4797.2005
P407
P577
2005-11-01T00:00:00Z